Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...

Gilead Sciences has been one of the best-performing large biotech companies over the past year, rising about 50%. That is largely due to excitement over its [long-acting HIV prevention drug]( ...

Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...

The CDC budget cuts could pose headwinds for HIV drugmakers like Gilead and Merck but are unlikely to severely cripple their ...

Yearly lenacapavir injection for HIV prevention shows safety and long-lasting effects, according to clinical trial results.

Researchers have discovered that Daphne pseudomezereum (commonly known as Onishibari) contains a substance inhibiting ...

The CDC's $1.3 billion Division of HIV Prevention is tasked with tracking infections across the United States.

Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, ...

Although officially banned for human consumption by the FDA, alkyl nitrites — commonly known as poppers — have been sold ...

The World Health Organisation has warned that the United States’ decision to halt foreign aid has disrupted the supply of HIV treatments in Nigeria, Haiti, Kenya, Lesotho, South Sudan, Burkina Faso, ...